“…Furthermore, individuals with obesity prescribed certain antiobesity medications may also face the stigma against people with a history of drug use. In particular, the prescription of naltrexone—a therapeutic also used to treat individuals with opioid disorders—to patients with obesity may increase their stigma burden by subjecting them to the biases associated with substance-use disorders 4…”